Biomerica (NASDAQ:BMRA) Releases Earnings Results

Biomerica (NASDAQ:BMRA) posted its quarterly earnings data on Monday. The company reported ($0.06) earnings per share (EPS) for the quarter, Zacks reports. Biomerica had a negative return on equity of 90.19% and a negative net margin of 100.52%.

Biomerica Stock Up 3.4 %

BMRA traded up $0.02 during trading on Monday, reaching $0.55. 65,689 shares of the company were exchanged, compared to its average volume of 2,214,404. Biomerica has a 12-month low of $0.24 and a 12-month high of $1.27. The company has a market cap of $10.14 million, a price-to-earnings ratio of -1.63 and a beta of 0.37. The company’s 50-day moving average is $0.66 and its two-hundred day moving average is $0.47.

About Biomerica

Biomerica, Inc, a biomedical technology company, develops, patents, manufactures, and markets diagnostic and therapeutic products for the detection and/or treatment of medical conditions and diseases worldwide. The company's diagnostic test kits are used to analyze blood, urine, nasal or fecal specimens from patients in the diagnosis of various diseases, food intolerances, and other medical complications; or to measure bacteria, hormones, antibodies, antigens, or other substances which may exist in the human body, stools, or blood in extremely small concentrations.